Literature DB >> 12034752

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.

Philipp J Kahle1, Manuela Neumann, Laurence Ozmen, Veronika Muller, Helmut Jacobsen, Will Spooren, Babette Fuss, Barbara Mallon, Wendy B Macklin, Hideo Fujiwara, Masato Hasegawa, Takeshi Iwatsubo, Hans A Kretzschmar, Christian Haass.   

Abstract

(Oligodendro)glial cytoplasmic inclusions composed of alpha-synuclein (alpha SYN) characterize multiple system atrophy (MSA). Mature oligodendrocytes (OLs) do not normally express alpha SYN, so MSA pathology may arise from aberrant expression of alpha SYN in OLs. To study pathological deposition of alpha SYN in OLs, transgenic mice were generated in which human wild-type alpha SYN was driven by a proteolipid protein promoter. Transgenic alpha SYN was detected in OLs but no other brain cell type. At the light microscopic level, the transgenic alpha SYN profiles resembled glial cytoplasmic inclusions. Strikingly, the diagnostic hyperphosphorylation at S129 of alpha SYN was reproduced in the transgenic mice. A significant proportion of the transgenic alpha SYN was detergent insoluble, as in MSA patients. The histological and biochemical abnormalities were specific for the disease-relevant alpha SYN because control green fluorescent protein was fully soluble and evenly distributed throughout OL cell bodies and processes. Thus, ectopic expression alpha SYN in OLs might initiate salient features of MSA pathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034752      PMCID: PMC1084143          DOI: 10.1093/embo-reports/kvf109

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  24 in total

1.  alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes.

Authors:  C Richter-Landsberg; M Gorath; J Q Trojanowski; V M Lee
Journal:  J Neurosci Res       Date:  2000-10-01       Impact factor: 4.164

2.  Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein.

Authors:  B Fuss; B Mallon; T Phan; C Ohlemeyer; F Kirchhoff; A Nishiyama; W B Macklin
Journal:  Dev Biol       Date:  2000-02-15       Impact factor: 3.582

3.  Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components.

Authors:  W P Gai; J H Power; P C Blumbergs; J G Culvenor; P H Jensen
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

4.  Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.

Authors:  S M Solano; D W Miller; S J Augood; A B Young; J B Penney
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

5.  The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.

Authors:  B C Campbell; C A McLean; J G Culvenor; W P Gai; P C Blumbergs; P Jäkälä; K Beyreuther; C L Masters; Q X Li
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

6.  Synucleins are a novel class of substrates for G protein-coupled receptor kinases.

Authors:  A N Pronin; A J Morris; A Surguchov; J L Benovic
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

7.  Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy.

Authors:  J E Duda; B I Giasson; T L Gur; T J Montine; D Robertson; I Biaggioni; H I Hurtig; M B Stern; S M Gollomp; M Grossman; V M Lee; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2000-09       Impact factor: 3.685

8.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

9.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

10.  Widespread alterations of alpha-synuclein in multiple system atrophy.

Authors:  D W Dickson; W Liu; J Hardy; M Farrer; N Mehta; R Uitti; M Mark; T Zimmerman; L Golbe; J Sage; A Sima; C D'Amato; R Albin; S Gilman; S H Yen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

View more
  135 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

Review 2.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

3.  Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress.

Authors:  Michael Riedel; Olaf Goldbaum; Michael Wille; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2010-08-20       Impact factor: 3.444

4.  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Authors:  Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Brian Spencer; Edward Rockenstein; Verena May; Juergen Winkler; Eliezer Masliah
Journal:  Exp Neurol       Date:  2012-01-16       Impact factor: 5.330

5.  Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy.

Authors:  D L Pountney; T M Treweek; T Chataway; Y Huang; F Chegini; P C Blumbergs; M J Raftery; W P Gai
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Proceedings of the 2nd International Meeting on Multiple System Atrophy, June 17-18, 2004, Rome, Italy.

Authors: 
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

7.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 8.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

9.  Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

10.  Bladder dysfunction in a transgenic mouse model of multiple system atrophy.

Authors:  Mathieu Boudes; Pieter Uvin; Silvia Pinto; Thomas Voets; Clare J Fowler; Gregor K Wenning; Dirk De Ridder; Nadia Stefanova
Journal:  Mov Disord       Date:  2013-02-20       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.